Global Medical Moulded Bottle Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Medical Moulded Bottle Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Type I Borosilicate Glass Molded Bottles
- 1.3.3 Type II Treated Soda-Lime-Silica Glass Molded Bottles
- 1.3.4 Type III Soda-Lime-Silica Glass Molded Bottles
- 1.3.5 Other
- 1.4 Market Analysis by Color
- 1.4.1 Overview: Global Medical Moulded Bottle Consumption Value by Color: 2021 Versus 2025 Versus 2032
- 1.4.2 Colorless Molded Bottle
- 1.4.3 Brown Molded Bottle
- 1.4.4 Other
- 1.5 Market Analysis by Capacity
- 1.5.1 Overview: Global Medical Moulded Bottle Consumption Value by Capacity: 2021 Versus 2025 Versus 2032
- 1.5.2 Capacity≤30mL
- 1.5.3 Capacity 30-100mL
- 1.5.4 Capacity 100-500mL
- 1.5.5 Capacity>500mL
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Medical Moulded Bottle Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Small-Volume Parenteral Preparations
- 1.6.3 Large-Volume Parenteral Preparations
- 1.6.4 Oral Liquid Preparations
- 1.6.5 Oral Solid Preparations
- 1.6.6 Other
- 1.7 Global Medical Moulded Bottle Market Size & Forecast
- 1.7.1 Global Medical Moulded Bottle Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Medical Moulded Bottle Sales Quantity (2021-2032)
- 1.7.3 Global Medical Moulded Bottle Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 SGD
- 2.1.1 SGD Details
- 2.1.2 SGD Major Business
- 2.1.3 SGD Medical Moulded Bottle Product and Services
- 2.1.4 SGD Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 SGD Recent Developments/Updates
- 2.2 Gerresheimer AG
- 2.2.1 Gerresheimer AG Details
- 2.2.2 Gerresheimer AG Major Business
- 2.2.3 Gerresheimer AG Medical Moulded Bottle Product and Services
- 2.2.4 Gerresheimer AG Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Gerresheimer AG Recent Developments/Updates
- 2.3 Adelphi Healthcare Packaging
- 2.3.1 Adelphi Healthcare Packaging Details
- 2.3.2 Adelphi Healthcare Packaging Major Business
- 2.3.3 Adelphi Healthcare Packaging Medical Moulded Bottle Product and Services
- 2.3.4 Adelphi Healthcare Packaging Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Adelphi Healthcare Packaging Recent Developments/Updates
- 2.4 SCHOTT Pharma
- 2.4.1 SCHOTT Pharma Details
- 2.4.2 SCHOTT Pharma Major Business
- 2.4.3 SCHOTT Pharma Medical Moulded Bottle Product and Services
- 2.4.4 SCHOTT Pharma Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 SCHOTT Pharma Recent Developments/Updates
- 2.5 DWK Life Sciences
- 2.5.1 DWK Life Sciences Details
- 2.5.2 DWK Life Sciences Major Business
- 2.5.3 DWK Life Sciences Medical Moulded Bottle Product and Services
- 2.5.4 DWK Life Sciences Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 DWK Life Sciences Recent Developments/Updates
- 2.6 Stoelzle Glass Group
- 2.6.1 Stoelzle Glass Group Details
- 2.6.2 Stoelzle Glass Group Major Business
- 2.6.3 Stoelzle Glass Group Medical Moulded Bottle Product and Services
- 2.6.4 Stoelzle Glass Group Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Stoelzle Glass Group Recent Developments/Updates
- 2.7 PGP Glass
- 2.7.1 PGP Glass Details
- 2.7.2 PGP Glass Major Business
- 2.7.3 PGP Glass Medical Moulded Bottle Product and Services
- 2.7.4 PGP Glass Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 PGP Glass Recent Developments/Updates
- 2.8 Shandong Pharmaceutical Glass
- 2.8.1 Shandong Pharmaceutical Glass Details
- 2.8.2 Shandong Pharmaceutical Glass Major Business
- 2.8.3 Shandong Pharmaceutical Glass Medical Moulded Bottle Product and Services
- 2.8.4 Shandong Pharmaceutical Glass Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Shandong Pharmaceutical Glass Recent Developments/Updates
- 2.9 Linuo Pharmaceutical Packaging
- 2.9.1 Linuo Pharmaceutical Packaging Details
- 2.9.2 Linuo Pharmaceutical Packaging Major Business
- 2.9.3 Linuo Pharmaceutical Packaging Medical Moulded Bottle Product and Services
- 2.9.4 Linuo Pharmaceutical Packaging Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Linuo Pharmaceutical Packaging Recent Developments/Updates
- 2.10 Nantong Xinde Medical Packing Material
- 2.10.1 Nantong Xinde Medical Packing Material Details
- 2.10.2 Nantong Xinde Medical Packing Material Major Business
- 2.10.3 Nantong Xinde Medical Packing Material Medical Moulded Bottle Product and Services
- 2.10.4 Nantong Xinde Medical Packing Material Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Nantong Xinde Medical Packing Material Recent Developments/Updates
- 2.11 Ningbo Xingya Rubber & Plastic
- 2.11.1 Ningbo Xingya Rubber & Plastic Details
- 2.11.2 Ningbo Xingya Rubber & Plastic Major Business
- 2.11.3 Ningbo Xingya Rubber & Plastic Medical Moulded Bottle Product and Services
- 2.11.4 Ningbo Xingya Rubber & Plastic Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Ningbo Xingya Rubber & Plastic Recent Developments/Updates
- 2.12 Shandong Dingxin Pharmaceutical Packaging Group
- 2.12.1 Shandong Dingxin Pharmaceutical Packaging Group Details
- 2.12.2 Shandong Dingxin Pharmaceutical Packaging Group Major Business
- 2.12.3 Shandong Dingxin Pharmaceutical Packaging Group Medical Moulded Bottle Product and Services
- 2.12.4 Shandong Dingxin Pharmaceutical Packaging Group Medical Moulded Bottle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Shandong Dingxin Pharmaceutical Packaging Group Recent Developments/Updates
3 Competitive Environment: Medical Moulded Bottle by Manufacturer
- 3.1 Global Medical Moulded Bottle Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Medical Moulded Bottle Revenue by Manufacturer (2021-2026)
- 3.3 Global Medical Moulded Bottle Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Medical Moulded Bottle by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Medical Moulded Bottle Manufacturer Market Share in 2025
- 3.4.3 Top 6 Medical Moulded Bottle Manufacturer Market Share in 2025
- 3.5 Medical Moulded Bottle Market: Overall Company Footprint Analysis
- 3.5.1 Medical Moulded Bottle Market: Region Footprint
- 3.5.2 Medical Moulded Bottle Market: Company Product Type Footprint
- 3.5.3 Medical Moulded Bottle Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Medical Moulded Bottle Market Size by Region
- 4.1.1 Global Medical Moulded Bottle Sales Quantity by Region (2021-2032)
- 4.1.2 Global Medical Moulded Bottle Consumption Value by Region (2021-2032)
- 4.1.3 Global Medical Moulded Bottle Average Price by Region (2021-2032)
- 4.2 North America Medical Moulded Bottle Consumption Value (2021-2032)
- 4.3 Europe Medical Moulded Bottle Consumption Value (2021-2032)
- 4.4 Asia-Pacific Medical Moulded Bottle Consumption Value (2021-2032)
- 4.5 South America Medical Moulded Bottle Consumption Value (2021-2032)
- 4.6 Middle East & Africa Medical Moulded Bottle Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 5.2 Global Medical Moulded Bottle Consumption Value by Type (2021-2032)
- 5.3 Global Medical Moulded Bottle Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 6.2 Global Medical Moulded Bottle Consumption Value by Application (2021-2032)
- 6.3 Global Medical Moulded Bottle Average Price by Application (2021-2032)
7 North America
- 7.1 North America Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 7.2 North America Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 7.3 North America Medical Moulded Bottle Market Size by Country
- 7.3.1 North America Medical Moulded Bottle Sales Quantity by Country (2021-2032)
- 7.3.2 North America Medical Moulded Bottle Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 8.2 Europe Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 8.3 Europe Medical Moulded Bottle Market Size by Country
- 8.3.1 Europe Medical Moulded Bottle Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Medical Moulded Bottle Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Medical Moulded Bottle Market Size by Region
- 9.3.1 Asia-Pacific Medical Moulded Bottle Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Medical Moulded Bottle Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 10.2 South America Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 10.3 South America Medical Moulded Bottle Market Size by Country
- 10.3.1 South America Medical Moulded Bottle Sales Quantity by Country (2021-2032)
- 10.3.2 South America Medical Moulded Bottle Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Moulded Bottle Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Medical Moulded Bottle Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Medical Moulded Bottle Market Size by Country
- 11.3.1 Middle East & Africa Medical Moulded Bottle Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Medical Moulded Bottle Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Medical Moulded Bottle Market Drivers
- 12.2 Medical Moulded Bottle Market Restraints
- 12.3 Medical Moulded Bottle Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Medical Moulded Bottle and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Medical Moulded Bottle
- 13.3 Medical Moulded Bottle Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Medical Moulded Bottle Typical Distributors
- 14.3 Medical Moulded Bottle Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Medical Moulded Bottle market size was valued at US$ 4004 million in 2025 and is forecast to a readjusted size of US$ 5540 million by 2032 with a CAGR of 4.8% during review period.
The Medical Moulded Bottle market covers pharmaceutical primary containers formed directly from molten glass, commonly described in the industry as moulded pharmaceutical glass bottles or vials. Production involves melting a formulated glass batch, cutting molten gobs, shaping them through press-and-blow or blow-and-blow moulding, annealing, optional surface treatment or coating, automated inspection, and clean packaging. The study focuses on clear and amber Type I borosilicate, Type II treated soda-lime-silica, Type III soda-lime-silica, and specialty moulded glass containers used for small- and large-volume parenteral preparations, oral liquids, tablets, capsules, and related pharmaceutical products. Critical performance attributes include bulk and surface hydrolytic resistance, thermal-shock resistance, light protection, extractables and leachables, dimensional accuracy, mechanical strength, cosmetic and particulate quality, neck-finish consistency, filling-line machinability, and container-closure integrity. The product boundary is therefore defined by pharmaceutical direct-contact use, moulded-glass forming technology, and compliance with applicable pharmacopoeial and pharmaceutical-packaging requirements.
Key Findings
In 2025, global Medical Moulded Bottle production reached approximately 33,261 M Units, with an average global market price of around US$ 117 per k unit.
Soda lime based Type II and Type III bottles form the market volume foundation
Parenteral preparations represent the value leading application pool for pharmaceutical moulded glass containers
Type I moulded borosilicate glass is the main premium upgrading direction for sensitive formulations
Supplier qualification depends on compatibility hydrolytic resistance dimensional consistency and container closure integrity
Market Trends
The market is shifting from general-purpose low-borosilicate and untreated soda-lime bottles toward containers selected through formulation-specific compatibility and stability assessment. Type I moulded borosilicate glass is gaining importance in sensitive injectables, lyophilized products, blood products, and preparations requiring greater thermal and hydrolytic resistance, while Type II surface-treated glass provides a cost-performance alternative for many acidic and neutral aqueous formulations. USP <660> defines Type I as borosilicate glass, Type II as surface-treated soda-lime-silica glass, and Type III as soda-lime-silica glass with moderate hydrolytic resistance, making this framework more suitable for global segmentation than the China-specific low- and medium-borosilicate terminology (USP <660>). Product development is also moving toward lighter bottles, more uniform wall and base distribution, improved freeze-drying performance, lower breakage, enhanced light protection, and internal barrier or siliconization treatments. Automated dimensional and cosmetic inspection, digital batch traceability, clean production between annealing and packing, hybrid or electric furnaces, higher cullet utilization, and lower-carbon manufacturing are becoming important qualification and procurement factors.
Market Dynamics
Drivers
Demand is supported by the continuing manufacture of generic injectables, antibiotics, vaccines, infusion products, lyophilized drugs, oral liquids, tablets, and veterinary medicines. Moulding technology provides high output, broad capacity ranges, robust container geometry, and attractive unit economics, particularly for medium- and large-capacity bottles. Pharmaceutical supply-chain localization is creating additional demand for qualified regional suppliers, while manufacturers are diversifying sourcing to reduce dependence on a single glass plant or geography. Glass also retains advantages in gas and moisture barrier performance, sterilization resistance, chemical inertness, transparency, and recyclability. Rising requirements for documented compatibility, stability, and container-closure integrity further favor established suppliers with pharmacopoeial testing capabilities, validated quality systems, automated inspection, and long-term batch consistency.
Restraints
Tubular glass competes strongly in small-format, high-value injectable vials because it can provide tight dimensional tolerances, lower weight, and extensive ready-to-use presentation options. Plastic bottles, polymer vials, blow-fill-seal containers, and flexible infusion bags compete in oral, ophthalmic, and large-volume parenteral applications where low weight and breakage resistance are priorities. Moulded-glass production also requires capital-intensive furnaces that operate continuously, exposing producers to energy costs, emission controls, refractory maintenance, and inflexible capacity adjustments. The weight and fragility of finished bottles increase transport and handling costs. Long pharmaceutical qualification cycles and the need to repeat stability or regulatory work following material, furnace, mould, surface-treatment, or production-site changes can slow customer conversion and new-product commercialization.
Opportunities
The strongest opportunities lie in Type I moulded borosilicate bottles for injectable, infusion, lyophilized, blood-product, and sensitive biological formulations, particularly where customers require the mechanical robustness of moulded glass at capacities larger than conventional tubular vials. Type II treated bottles can expand as an economical solution for compatible acidic and neutral aqueous products; USP recognizes Type II performance as suitable for most such parenteral and non-parenteral preparations (USP suitability guidance). Additional opportunities include lightweight designs, improved glass distribution, low-friction external coatings, internal barrier treatments, higher-quality amber glass, cleaner ready-to-process packaging, serialization and traceability, and integrated bottle-stopper-cap compatibility services. Capacity localization in Asia, the Middle East, Africa, and Latin America also supports suppliers able to combine international compliance with competitive regional production.
Challenges
The central technical challenge is maintaining stable pharmaceutical performance across glass composition, melting conditions, mould wear, surface treatment, annealing, inspection, and packaging. Suppliers must control alkali release, inner-surface durability, delamination or glass-flake risk, extractable elements, particles, cracks, checks, wall-thickness variation, neck dimensions, thermal shock, and light transmission. Container-closure integrity depends on the combined performance of the bottle finish, elastomeric stopper, aluminum seal, filling process, and storage conditions, rather than the bottle alone. The European Pharmacopoeia’s revision of Chapter 3.2.1 reinforces the importance of clearly defined hydrolytic-resistance tests and wall-thickness-based spectral-transmission assessment for colored glass (EDQM). Producers must simultaneously manage energy decarbonization, borate and soda-ash supply, furnace reliability, increasingly stringent defect limits, and customer demands for lower prices.
Industry Chain Analysis
Upstream inputs include silica sand, soda ash, limestone, boric acid and borates, alumina, refining agents, colorants, cullet, refractory materials, moulds, inspection equipment, natural gas, electricity, and industrial gases. Complementary packaging inputs include elastomeric stoppers, aluminum seals, plastic caps, liners, and secondary packaging. Midstream production comprises batch formulation, melting at temperatures that can reach approximately 1,600°C, gob preparation, press-and-blow or blow-and-blow forming, annealing, inner-surface treatment, siliconization or protective coating, dimensional and cosmetic inspection, and controlled packing; this process is illustrated by SGD Pharma’s moulded-vial manufacturing route (SGD Pharma). Downstream customers include pharmaceutical manufacturers, biotechnology companies, vaccine producers, generic-drug companies, infusion manufacturers, CDMOs, diagnostic and veterinary-product companies, and fill-finish operators. Value creation is concentrated in glass formulation, mould and furnace control, defect prevention, clean handling, regulatory documentation, drug compatibility, closure-system matching, and dependable multi-year supply.
Segment Insights
Type I borosilicate glass molded bottles represent the premium segment, providing high bulk hydrolytic resistance, thermal-shock resistance, and broad formulation compatibility. They are primarily used for sensitive injectables, lyophilized drugs, biological products, vaccines, blood products, and selected infusion preparations, and constitute the principal direction of material upgrading. Type II treated soda-lime-silica glass molded bottles achieve high surface hydrolytic resistance through inner-surface treatment and provide a cost-performance solution for compatible acidic and neutral aqueous parenteral preparations. Competition in this segment focuses on treatment uniformity, surface durability, alkali release, and batch consistency. Type III soda-lime-silica glass molded bottles offer moderate hydrolytic resistance and competitive manufacturing costs, forming an important volume base in oral liquids, tablets, capsules, and other non-parenteral preparations; their use in parenteral products requires formulation-specific stability and compatibility confirmation. Other products include coated, lightweight, high-strength, aluminosilicate, quartz, and other specialty molded glass bottles developed for enhanced barrier performance, light protection, filling-line efficiency, or sensitive formulations. Market value growth is increasingly driven by Type I and premium Type II products, while Type III products retain scale advantages in standardized, cost-sensitive applications.
Downstream Market Opportunities
Small-volume parenteral preparations provide the principal value-upgrading opportunity for medical molded bottles. Sensitive injectables, antibiotics, lyophilized drugs, vaccines, biological products, and diagnostic reagents are increasing demand for Type I borosilicate and qualified Type II bottles with strong hydrolytic resistance, dimensional consistency, low particulate risk, and reliable container-closure integrity. Large-volume parenteral preparations, including infusions, blood products, and irrigation solutions, create opportunities for lightweight, mechanically robust bottles with uniform wall distribution and high thermal-shock resistance, although this segment continues to face competition from polymer containers and flexible bags. Oral liquid preparations represent a broad volume market for clear and amber Type III bottles, with opportunities in light protection, accurate dispensing, tamper evidence, and child-resistant closure systems. Oral solid preparations support demand for cost-efficient wide-mouth bottles used for tablets, capsules, granules, and powders. Other pharmaceutical applications, including veterinary medicines, topical liquids, diagnostics, and specialty formulations, offer opportunities for customized capacities, neck finishes, colors, coatings, and small-batch supply. Suppliers can create additional value through integrated bottle-stopper-cap solutions, compatibility support, automated inspection, clean packaging, and regional production.
Regional Insights
Asia Pacific is the principal unit-volume manufacturing and consumption region, supported by China’s large generic-drug, injectable, infusion, and oral-medicine industries and by expanding pharmaceutical production elsewhere in Asia. China combines established high-volume soda-lime and low-borosilicate capacity with accelerating investment in medium-borosilicate and Type I moulded products. Shandong Pharmaceutical Glass and Linuo are important integrated regional suppliers, while PGP Glass provides Type I, II, and III pharmaceutical bottles and dedicated Type I moulded capacity from South Asia (PGP Glass).
Europe remains a key technology and qualification center, with strong capabilities in Type I–III glass, surface treatment, specialty designs, and regulated parenteral packaging. North American demand is oriented toward high-quality injectables, vaccines, compounding, diagnostics, and specialty pharmaceutical packaging, although regional supply also relies on European and Asian production networks. Latin America, the Middle East, and Africa offer longer-term opportunities through generic medicines, hospital infusions, and local fill-finish investment, but supplier selection remains sensitive to landed cost, regulatory support, minimum order quantities, and security of supply.
Competitive Landscape Analysis
Core manufacturers include SGD Pharma; Gerresheimer’s Moulded Glass division, which incorporates the Bormioli Pharma business; Shandong Pharmaceutical Glass; Linuo Pharmaceutical Packaging; and PGP Glass, together with Stoelzle Glass Group, Beatson Clark, Nantong Xinde, and Shandong Dingxin. DWK Life Sciences participates in the specialist segment through its WHEATON Type I moulded serum bottles, while “Piramal” should be updated to its current corporate name, PGP Glass. Bormioli Pharma has been part of Gerresheimer since December 2024. As of August 2026, the combined Moulded Glass business remains a separately managed Gerresheimer division, and the proposed sale process has been postponed beyond fiscal year 2026 (Gerresheimer). Competition focuses on qualified glass types, pharmaceutical compatibility, defect rates, dimensional consistency, coating capabilities, automated inspection, total delivered cost, regulatory and technical support, and continuity of supply, making a single universal market ranking inappropriate.
Report Scope
This report is a detailed and comprehensive analysis for global Medical Moulded Bottle market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Moulded Bottle market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Medical Moulded Bottle market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Medical Moulded Bottle market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global Medical Moulded Bottle market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Moulded Bottle
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Moulded Bottle market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SGD, Gerresheimer AG, Adelphi Healthcare Packaging, SCHOTT Pharma, DWK Life Sciences, Stoelzle Glass Group, PGP Glass, Shandong Pharmaceutical Glass, Linuo Pharmaceutical Packaging, Nantong Xinde Medical Packing Material, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Medical Moulded Bottle market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Type I Borosilicate Glass Molded Bottles
Type II Treated Soda-Lime-Silica Glass Molded Bottles
Type III Soda-Lime-Silica Glass Molded Bottles
Other
Market segment by Color
Colorless Molded Bottle
Brown Molded Bottle
Other
Market segment by Capacity
Capacity≤30mL
Capacity 30-100mL
Capacity 100-500mL
Capacity>500mL
Market segment by Application
Small-Volume Parenteral Preparations
Large-Volume Parenteral Preparations
Oral Liquid Preparations
Oral Solid Preparations
Other
Major players covered
SGD
Gerresheimer AG
Adelphi Healthcare Packaging
SCHOTT Pharma
DWK Life Sciences
Stoelzle Glass Group
PGP Glass
Shandong Pharmaceutical Glass
Linuo Pharmaceutical Packaging
Nantong Xinde Medical Packing Material
Ningbo Xingya Rubber & Plastic
Shandong Dingxin Pharmaceutical Packaging Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Medical Moulded Bottle product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Moulded Bottle, with price, sales quantity, revenue, and global market share of Medical Moulded Bottle from 2021 to 2026.
Chapter 3, the Medical Moulded Bottle competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Moulded Bottle breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Moulded Bottle market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Moulded Bottle.
Chapter 14 and 15, to describe Medical Moulded Bottle sales channel, distributors, customers, research findings and conclusion.